The administration’s highest-ranking COVID official built his wealth through billing practices that have been alleged as fraud, triggering hundreds of millions in fines.
Medicare
Posted inTAP
Invisible Privatization
Today on TAP: Medicare, the crown jewel of American health care, is being stealthily devoured by health insurance companies.
Posted inHealth and Social Policy
Biden’s Big Chance to Lower Drug Prices
A decision on whether to open a costly cancer drug to generic competition will be made shortly. It doesn’t require congressional approval.
Posted inHealth and Social Policy
The Dark History of Medicare Privatization
Medicare Advantage was supposed to be a money-saver. It’s now become a costly, unaccountable cash cow for private insurance companies that is swallowing traditional Medicare.
Posted inHealth and Social Policy
Biden Regulators Take Action on Hidden Pharma Monopolies
A proposed rule would eliminate the ability of pharmacy benefit managers to extract profits after a prescription drug is sold.
Posted inPolitics
Toxic Ads and How to Counter Them
Anticipating and rebutting likely lines of attack is the best strategy, on both partisan and civic grounds.
Posted inBuilding Back America
The Drug Price/Tax Break Quid Pro Quo
Democrats in high-tax states cut a deal on the Build Back Better Act.
Posted inTAP
World’s Biggest Half-Full, Half-Empty Glass
Today on TAP: Biden’s bill is historically great and bitterly disappointing.
Posted inBuilding Back America
What’s in the Build Back Better Framework
It has its selling points. But it doesn’t appear to meet the test of permanent, hassle-free, and meaningful.
Posted inMoney, Politics, and Power
The Drug Industry–Backed PAC Trying to Spike the Biden Agenda
Center Forward is funding practically all the corporate Democrats making trouble in Congress.